Answers are grounded in this paper and cite their sources.
Methods and software tools for optimal design in nonlinear mixed effect models, based on the Fisher information matrix, have been developed for a decade.1,2 Academic groups regularly proposed new versions.3–5 Present tools do not incorporate adaptive designs for these models although prior information is needed and adaptive designs are increasingly used in drug development.6 We conducted a study among drug companies of the Drug and Disease Model Resources consortium7 to identify current practices and expectations. CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e46; doi: 10.1038/psp.2013.19 ; advance online publication 5 June 2013
No takes yet. Share an insight, caveat, or question.
Mentré et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: